Masayuki Haruta

1.0k total citations
44 papers, 770 citations indexed

About

Masayuki Haruta is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Masayuki Haruta has authored 44 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 13 papers in Genetics and 10 papers in Oncology. Recurrent topics in Masayuki Haruta's work include Epigenetics and DNA Methylation (15 papers), Renal and related cancers (14 papers) and Neuroblastoma Research and Treatments (9 papers). Masayuki Haruta is often cited by papers focused on Epigenetics and DNA Methylation (15 papers), Renal and related cancers (14 papers) and Neuroblastoma Research and Treatments (9 papers). Masayuki Haruta collaborates with scholars based in Japan, United Kingdom and Indonesia. Masayuki Haruta's co-authors include Yasuhiko Kaneko, Shohei Honda, Yasuhito Arai, Hiroshi Horie, Masahiro Fukuzawa, Hajime Okita, Akira Nakagawara, Miki Ohira, Eiso Hiyama and Mitsuo Oshimura and has published in prestigious journals such as Oncogene, Current Biology and Biochemical and Biophysical Research Communications.

In The Last Decade

Masayuki Haruta

42 papers receiving 764 citations

Peers

Countries citing papers authored by Masayuki Haruta

Since Specialization

Citations

This map shows the geographic impact of Masayuki Haruta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Haruta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Haruta more than expected).

Fields of papers citing papers by Masayuki Haruta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Haruta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Haruta. The network helps show where Masayuki Haruta may publish in the future.

Co-authorship network of co-authors of Masayuki Haruta

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Haruta. A scholar is included among the top collaborators of Masayuki Haruta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Haruta. Masayuki Haruta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-γ-induced Apoptosis in Urothelial Cancer 2024 ·Anticancer Research ·(unknown), Kiyohiro Ando, Noriko Motoi, Toshihiko Iizuka, Masaharu Inoue, (unknown), (unknown), Hisanori Takenobu, Masayuki Haruta, (unknown), Yoh Matsuoka, Takehiko Kamijo, Yukio Kageyama	1
2	Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma 2023 ·Biochemical and Biophysical Research Communications ·Kiyohiro Ando, (unknown), Noriko Motoi, Toshihiko Iizuka, Masaharu Inoue, (unknown), (unknown), Hisanori Takenobu, Masayuki Haruta, (unknown), Yoh Matsuoka, Takehiko Kamijo, Yukio Kageyama	1
3	ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors 2023 ·BMC Cancer ·(unknown), Jesmin Akter, Hisanori Takenobu, (unknown), (unknown), (unknown), Masayuki Haruta, (unknown), Tomoko Wada, Miki Ohira, Kiyohiro Ando, Takehiko Kamijo	8
4	Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells 2023 ·Cancer Science ·(unknown), Hisanori Takenobu, (unknown), Masayuki Haruta, (unknown), (unknown), Miki Ohira, Michinori Funato, Junya Toguchida, Kenji Osafune, Tatsutoshi Nakahata, Hiroaki Kanda, Takehiko Kamijo	6
5	Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma 2022 ·Anticancer Research ·(unknown), Kiyohiro Ando, Masaharu Inoue, (unknown), (unknown), (unknown), Hisanori Takenobu, Masayuki Haruta, Toshihiko Iizuka, Takehiko Kamijo, Yukio Kageyama	15
6	Combined Genetic and Chromosomal Characterization of Wilms Tumors Identifies Chromosome 12 Gain as a Potential New Marker Predicting a Favorable Outcome 2018 ·Neoplasia ·Masayuki Haruta, Yasuhito Arai, Hajime Okita, Yukichi Tanaka, Tetsuya Takimoto, Ryuichi P. Sugino, Yasuhiro Yamada, Takehiko Kamijo, Takaharu Oue, Masahiro Fukuzawa, Tsugumichi Koshinaga, Yasuhiko Kaneko	7
7	EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications 2018 ·Oncogene ·Zhenghao Li, Hisanori Takenobu, (unknown), (unknown), Masayuki Haruta, (unknown), (unknown), (unknown), (unknown), Jesmin Akter, Ryuichi P. Sugino, Atsuko Nakazawa, Akira Nakagawara, Hiroyuki Aburatani, Miki Ohira, Takehiko Kamijo	53
8	Anaplastic histology Wilms’ tumors registered to the Japan Wilms’ Tumor Study Group are less aggressive than that in the National Wilms’ Tumor Study 5 2016 ·Pediatric Surgery International ·Takaharu Oue, Tsugumichi Koshinaga, Tetsuya Takimoto, Hajime Okita, Yukichi Tanaka, Miwako Nozaki, Masayuki Haruta, Yasuhiko Kaneko, Masahiro Fukuzawa	11
9	RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients 2014 ·Cancer Letters ·Masayuki Haruta, Takehiko Kamijo, Akira Nakagawara, Yasuhiko Kaneko	8
10	Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy 2013 ·BMC Cancer ·Mamoru Takada, Toru Higuchi, (unknown), Hiroyuki Takei, Masayuki Haruta, Junko Watanabe, Fumio Kasai, Kenichi Inoue, Masafumi Kurosumi, Masaru Miyazaki, Aiko Sato‐Otsubo, Seishi Ogawa, Yasuhiko Kaneko	22
11	Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children 2012 ·Cancer Science ·Masayuki Haruta, Yasuhito Arai, Naoki Watanabe, (unknown), Shohei Honda, (unknown), Fumio Kasai, Hisaya Nakadate, Hiroshi Horie, Hajime Okita, Junichi Hata, Masahiro Fukuzawa, Yasuhiko Kaneko	20
12	Meiosis error and subsequent genetic and epigenetic alterations invoke the malignant transformation of germ cell tumor 2012 ·Genes Chromosomes and Cancer ·(unknown), Yasuhito Arai, Masayuki Haruta, (unknown), Tadashi Ariga, Tadashi Kajii, Yasuhiko Kaneko	6
13	Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor 2009 ·Genes Chromosomes and Cancer ·(unknown), Masayuki Haruta, Yasuhito Arai, Fumio Kasai, (unknown), Tadashi Ariga, Hajime Okita, Masahiro Fukuzawa, Junichi Hata, Hiroshi Horie, Yasuhiko Kaneko	31
14	Duplication of paternal IGF2 or loss of maternal IGF2 imprinting occurs in half of Wilms tumors with various structural WT1 abnormalities 2008 ·Genes Chromosomes and Cancer ·Masayuki Haruta, Yasuhito Arai, (unknown), Naoki Watanabe, Shohei Honda, (unknown), Hidenobu Soejima, Hisaya Nakadate, Hajime Okita, Junichi Hata, Masahiro Fukuzawa, Yasuhiko Kaneko	37
15	Centrosome amplification is correlated with ploidy divergence, but not with MYCN amplification, in neuroblastoma tumors 2008 ·Cancer Genetics and Cytogenetics ·Daisuke Fukushi, Naoki Watanabe, Fumio Kasai, Masayuki Haruta, Akira Kikuchi, Atsushi Kikuta, Koji Kato, Hisaya Nakadate, Yukiko Tsunematsu, Yasuhiko Kaneko	5
16	Experience-Driven Axon Retraction without Binocular Imbalance in Developing Visual Cortex 2007 ·Current Biology ·Masayuki Haruta, Yoshio Hata	12
17	Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type 2007 ·Genes Chromosomes and Cancer ·Naoki Watanabe, Masayuki Haruta, Hidenobu Soejima, Daisuke Fukushi, Kinji Yokomori, Hisaya Nakadate, Hajime Okita, (unknown), Masahiro Fukuzawa, Yasuhiko Kaneko	13
18	Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma 2006 ·Pediatric Blood & Cancer ·(unknown), Masayuki Haruta, Fumiaki Sasaki, Naoki Watanabe, Yukiko Tsunematsu, Atsushi Kikuta, Yasuhiko Kaneko	29
19	A new imprinted cluster on the human chromosome 7q21-q31, identified by human-mouse monochromosomal hybrids 2003 ·Genomics ·(unknown), Makiko Meguro, Hidetoshi Hoshiya, Masayuki Haruta, Yuki Sakamoto, Mitsuo Oshimura	66
20	Predominant maternal expression of the mouse Atp10c in hippocampus and olfactory bulb 2003 ·Journal of Human Genetics ·Akiko Kashiwagi, Makiko Meguro, Hidetoshi Hoshiya, Masayuki Haruta, Fumitoshi Ishino, Toshiyuki Shibahara, Mitsuo Oshimura	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact